Svati Shah
@SvatiShah
Followers
3K
Following
9K
Media
128
Statuses
2K
Cardiologist studying genetics and metabolism
Durham, NC
Joined October 2017
Congratulations @DrPRao! So well deserved!!.
Huge s/o to the Gerszten lab (peer mentorship was invaluable!) and scientific advisory committee:.@JenHoCardiology .@SvatiShah .@longlabstanford .Dr. Benjamin Levine. Excited to share more insights as this project develops!.
1
0
3
RT @JCardFail: Should there be systematic genetic screening for the most common variants of TTR amyloidosis?. This piece explores the gaps….
0
12
0
RT @AndrewJSauer: 📰A professional update 🔥. My recent boss, mentor, and friend @MkosiborodMD recently left @MidAmericaHeart and @saintlukes….
0
9
0
RT @AHAScience: CPET is essential for comprehensive care of patients w/ CHD, offering valuable prognostic insights & assisting in clinical….
0
9
0
RT @FudimMarat: 1/ 🌟 New treatment paradigm in heart failure! The REMOTE-HF study explored BAY 2413555, a novel M2 receptor modulator aimin….
0
16
0
Fantastic talk from super ⭐️ @jregan2012 at @DukeMedSchool Precision Genomics Collaboratory retreat, 2nd place for best oral presentation! Metabolic pathways and snRNAseq for epicardial and pericoronary fat
1
1
28
Awesome talk from the incredible @drmrscoles at @DukeMedSchool genomics symposium. Cool work w/ a homegrown pipeline for WGS to identify causative genetic variants in families with arrhythmias. Sara is a rising ⭐️ in EP and arrhythmia genetics 🧬, keep an 👁️ out for her!
2
2
29
RT @MariosGeorgakis: This @CellCellPress paper making the most of the #proteomics resource of the UK Biobank is a great Sunday read📖❗️. 🔗ht….
0
48
0
RT @pnatarajanmd: Free nationwide genetic carrier screening of 10K reproductive couples during current or planned pregnancy offered during….
0
4
0
RT @CircHF: SGLT2i demonstrate common (fatty acid) and distinct (ketogenic) metabolic signatures across the LVEF spectrum @senthil_selv @Sv….
0
4
0
Congratulations, great work @senthil_selv! A great step towards use of exogenous ketone therapy in HF.
Our phase I study of 2 doses of exogenous ketones detailing PK and metabolic profiling in HFrEF by background SGLT2i. Simpub #AHA24 & @JACCJournals #JACCBTS. 🙏 @SvatiShah @MarguliesLab @robmentz @FudimMarat and outstanding team. @DukeHeartCenter @DukeMPI
1
1
26
RT @DrSafarova: #AHA24 Genomics and Precision Medicine Council @American_Heart on training in #CardioGenomics.Thrilled to see major efforts….
0
2
0
RT @David_Ouyang: Excited to be at #AHA24 and share the excellent work of our trainees, collaborators, and friends!
0
14
0
RT @FudimMarat: #AHA24 Early Career Spotlight on some amazing young and promising talent in the space of CV medicine. From Software to Hemo….
0
5
0
RT @dramitkhera: Key programming for women in cardiology at #AHA24 Thanks to the developers and participants of these excellent sessions. @….
0
15
0
RT @mad_sters: NEW @AHAScience Scientific Statement from the Inaugural Primary Care Science Committee !! ."Role of Primary Care in Achievin….
0
24
0
RT @RajgopalRadhika: New science advisory on Gene Therapy in CVD👇👇thanks to @P_StLaurent .@yurikim_mdphd @APLandstrom @SvatiShah @Joseph_C_….
0
3
0
RT @yurikim_mdphd: Very excited to share our AHA Science Advisory where we discuss current promises and limitations of gene therapy in CVD.….
0
9
0
RT @AHAScience: CVD is the leading cause of 🌏 morbidity & mortality. Many are caused by damaging DNA 🧬 variants and require lifelong treat….
0
24
0